BioScrip (BIOS) Misses Q3 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/29/2026
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- HF Sinclair plans to spin off lubricants unit, close Canadian refinery
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- Crude Inventory Fell 7.2 Million Barrels Last Week - EIA
- S&P 500 ends higher as investors await tech earnings
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
- After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
BioScrip Reports Third Quarter 2015 Financial Results
November 4, 2015 7:00 AM ESTConsolidated Adjusted EBITDA of $6.2 Million
Results Demonstrate Progress Against Financial Improvement Plan
Reaffirms 2016 Adjusted EBITDA Guidance of Between $50 Million - $60 Million
ELMSFORD, N.Y.--(BUSINESS WIRE)-- BioScrip, Inc. (NASDAQ: BIOS) (the Company) today announced 2015 third quarter financial results.
Third Quarter Highlights
Consolidated Adjusted EBITDA was $6.2 million, primarily due to the early positive contributions of BioScrips previously announced plan to reduce costs and focus on its core infusion business; Revenue... More